Navigation Links
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
Date:5/16/2013

position of the established players in the MS marketplace.

Market growth will be driven by the launch of new DMTs, including several oral therapies that will increase overall treatment rates, and novel DMTs, such as siponimod, that specifically target the large population of MS patients in the UK who have a progressive MS subtype. However, a high rate of generic substitution once key branded products go off patent is an important barrier that limits the market size.

Scope

- Overview of the Multiple Sclerosis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.- Sales forecast for the top drugs in the UK from 2012-2022.- Analysis of the impact of key events as well the drivers and restraints affecting the UK Multiple Sclerosis market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return- Stay ahead of the competition by understanding the changing competitive landscape for Multiple Sclerosis- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential- Make more informed business decisions from insightful and in-depth analysis of drug performance- Obtain sales forecast for drugs from 2012-2022 in the UK1 Table of Contents1 Table of Contents 41.1 List of Tables 71.2 List of Figures 92 Introduction 102.1 Catalyst 102.2 Related Reports 113 Disease Overview 133.1 Etiology and Pathophysiology 133.1.1 Etiology 133.1.2 Pathophysiology 143.1.3 Classification of Multiple Sclerosis 153.2 Symptoms 173.2.1 Prognosis 183.2.2 Quality of Life 194 Disease Management 204.1 Diagnosis 204.2 Treatment Overview 234.2.1 Management of Acute Relapse 244.2.2 Treatment with Disease-Modifying Therapies 244.2.3 Sympto
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
5. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
6. Food Recalls Driven by Companies Issuing Multiple Recalls in the First Quarter of 2013, According to Latest ExpertRECALL Index
7. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
8. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
9. Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
10. For Pharma Companies, Launching Multiple Similar Products Can Be a "Good Problem" but Requires Smart Resourcing
11. Deploying an Effective Pay for Performance Bonus System that Works Across Multiple Industry Sectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... N.C. , June 1, 2015  bioMérieux, a ... diagnostics, has been invited to join the White ... antibiotic use in the U.S. as a means to ... sectors, will gather tomorrow, June 2, 2015, to discuss ... five years to slow the emergence of antibiotic-resistant bacteria, ...
(Date:6/1/2015)... , June 1, 2015 The Middle Eastern ... diagnostic tool which is replacing CT because of its higher ... more popular one between the two available systems of MRI, ... in the top and bottom and do not enclose the ... There is a study which shows that one in every ...
(Date:6/1/2015)... , June 1, 2015 NEOVIA ONCOLOGY ... engaged in the development and commercialization of novel, ... it has met with the U.S. Food and ... filing of an Investigational New Drug (IND) application ... a result of the meeting, Neovia has clarified ...
Breaking Medicine Technology:bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Neovia Oncology Announces First IND Meeting 2
... 2010 Sequenom, Inc. (Nasdaq: SQNM ) ... Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized ... study is designed to evaluate the clinical performance of ... detection of an overabundance in maternal blood of chromosome ...
... 22, 2010 Renal Advantage and Liberty Dialysis, which last ... of dialysis services in the U.S., today announced that they ... were not disclosed – was completed on December 17, 2010. ... patients in 260 locations in 32 states. "The ...
Cached Medicine Technology:Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 2Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 3Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 4Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Marcy Herrmann as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in life ... for professional women, boasting more than 700,000 members and ... to present Marcy with this distinction,” said NAPW President ...
(Date:6/1/2015)... 02, 2015 The National Association ... a 2015-2016 inductee into its VIP Woman of ... prestigious distinction for leadership in business. NAPW is ... women, boasting more than 700,000 members and over ... welcome Kathy into this exceptional group of professional ...
(Date:6/1/2015)... Carson Energy also announced they have selected ... AdvantaIRA Trust, LLC is the country’s largest self-directed IRA ... positions using IRA’s does 2 things:, 1. It gives ... if there current cash position will not allow for ... Carson and their investors to be able to participate ...
(Date:6/1/2015)... LONE TREE, CO (PRWEB) June 01, 2015 ... to announce they have been named an Ultherapy® ... Ultherapy. Atagi Plastic Surgery and Skin Aesthetics is one ... by Ulthera as a premier treatment provider. , ... with Ultherapy in the Denver area has led the ...
(Date:6/1/2015)... 2015 On May 14, 2015, the ... hosted the Cherry Creek Chamber of Commerce for the ... care centers typically do not offer primary care services ... Cherry Creek Urgent Care staff to schedule family care ... 5:30 to 7:30 p.m. the center hosted presidents, CEOs, ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2
... who are diagnosed with prostate cancer by biopsy are more ... aggressive// case of the disease than the biopsy results would ... Medical Center researcher. ,The finding suggests that misleading ... to receive inadequate or inappropriate treatment that is not aggressive ...
... new blood thinner, one of the first signs the drug ... bleeds and bruising,// an inconvenient side effect of preventing the ... and stroke. While potentially life-saving, the drugs can also pose ... monitoring of blood levels. ,So when he didn’t ...
... disabled? Can parents arrange surgical interventions on their children, hoping life ... a raised in a beated debate in the US. ... stopped developing when she was only three months old. ... recognize her family members and to enjoy music. But she can ...
... news. His colon cancer, which was treated two years ... with chemotherapy in 2005 after doctors removed his colon in ... metastatic. Yet after recent surgery to remove a growth ... liver. ,Though patients often can be cured of ...
... pill to control high blood pressure and new drugs ... Clinic researchers have designed two promising new cardiovascular treatment ... pill form to lower high blood pressure and a ... kidney function. ,In the process, they ...
... children, yet the number of pediatric orthopedists trained to ... decreasing nationwide. The management of fractures in children is ... is needed to provide the best care for these ... for Special Surgery (HSS). ,Fractures in ...
Cached Medicine News:Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Debate in US: Who Should Decide for Disabled People? 2Health News:White House Press Secretary to Battle Second Round of Colon Cancer 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 3
Idophor PVP Scrub Winged Sponges...
Triad Plus PVP-I Scrub Winged Sponges...
... preoperative skin preparation an ... site infections. Scrub Care brand ... offer high efficacy and safety ... Prevail-Fx offers the highest level ...
Single-dose applicator. Provides a superior, hands-off "friction scrub," enhancing the efficacy of the antiseptic solution it delivers....
Medicine Products: